Posted on

Esophagus Tissue Arrays

Need more information, quote or place an order?  Please email to: info@vitrovivo.com

SKU#

DESCRIPTION

CASE

CORE

PRICE ($)

T024 Esophageal cancer test tissue array (4x (2×3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores 6 24 52.50
ES482 Esophageal cancer tissue array with esophagus tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores 48 48 172.50
BC02012b Esophageal carcinoma (multi-tissue combined panel) tissue array, 72 cases/72 cores 72 72 337.50
ES901 Esophagus cancer and esophagus tissue array, including pathology grade, TNM and clinical stage, 30 cases/90 cores 30 90 382.50
ES208b Esophagus cancer and esophagus tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing ES208a 64 192 682.50
ES8011a Esophagus cancer and normal tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing ES8011 40 80 382.50
ES244 Esophagus cancer test tissue array (4x (2×3)array), including pathology grade, TNM and clinical stage, 6 cases/24 cores 12 24 82.50
T022a Esophagus cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T022b 12 24 82.50
T022b Esophagus cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T022c 12 24 82.50
ES723 Esophagus cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 23 cases/ 72 cores 23 72 382.50
ES701 Esophagus cancer tissue array with matched adjacent normal esophagus tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores 35 70 247.50
ES1503 Esophagus cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores 50 150 322.50
ES1504 Esophagus cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/150 cores 50 150 322.50
T021b Esophagus cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T021a 6 24 60.00
ES484 Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/ 48 cores 24 48 210.00
ES966 Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores 48 96 322.50
ES962 Esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing ESC962 48 96 322.50
ES902 Esophagus cancer with adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 45 cases/90 cores 45 90 382.50
ES482b Esophagus cancer with esophagus tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing ES482a 48 48 172.50
ES208 Esophagus cancer with esophagus tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 69 cases/208 cores 69 208 682.50
ES483 Esophagus cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 16 cases/48 cores 16 48 210.00
ESO502 Esophagus cancer with matched esophagus tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 25 cases/50 cores 50 50 202.50
ES810a Esophagus cancer with matched lymph node metastatic carcinoa tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing ES810 40 80 382.50
T022c Esophagus cancer with normal tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T022b 12 24 82.50
BC02003 Esophagus disease spectrum (esophageal cancer progression) tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores 72 72 337.50
ES352 Esophagus squamous cell carcinoma (grade II) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores 35 35 210.00
ES353 Esophagus squamous cell carcinoma (grade III) tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores 35 35 210.00
ES601 Esophagus squamous cell carcinoma tissue array with matched cancer adjacent esophagus tissue, including pathology grade, TNM and clinical stage, 30 cases/60 cores 30 60 247.50
ES961 Esophagus squamous cell carcinoma tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/96 cores 48 96 382.50
ES351 Esophagus squamous cell carcinoma tissue array, including pathology grade, TNM and clinical stage, 35 cases/35 cores 35 35 210.00
ES502 Esophagus squamous cell carcinoma tissue array, including pathology grade, TNM and clinical stage, 50 cases/50 cores 50 50 382.50
ESO501 Esophagus squamous cell carcinoma with esophagus tissue array (2010 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores 50 50 202.50
ES1922 Esophagus squamous cell carcinoma with matched adjacent nomal esophagus tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores 96 192 592.50
ES2001a Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue and metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 120 cases/200 cores, replacing ES2001 120 200 592.50
ES1505 Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores 50 150 322.50
BN02014 Esophagus tissue with esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores 80 80 382.50
BC001113a Esophagus, cardia cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing BC001113 50 50 337.50
ES8012 Middle-advanced stage esophagus cancer tissue array with metastasis tissue?including pathology grade, TNM and clinical stage, 80 cases/80 cores 80 80 337.50
ES1921 Middle-advanced stage esophagus cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores 96 192 592.50
ES702 Multiple esophagus cancer tissue array with matched cancer adjacent normal tissue, including pathology grade, TNM and clinical stage, 35 cases/70 cores 35 70 247.50

TMA Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.